Alendronate Sodium   4

Background
The Defense Logistics Agency (DLA), Directorate of Medical Materiel provides pharmaceutical products for the Department of Defense (DoD) to its customers through its Pharmaceutical Prime Vendor program. The Department of Veterans Affairs (VA) provides pharmaceutical products to its customers as well as the Indian Health Service (IHS) and the Bureau of Prisons (BoP) through the VA Pharmaceutical Prime Vendor Program. Hereafter these programs are collectively referred to as the “PPV.” A prime vendor is an independent business concern that functions as a purchaser's primary source for specified classes of products and is responsible for the delivery of goods produced by various suppliers. As a part of the Pharmaceutical Prime Vendor Program, this solicitation will establish a national contract for the items listed in the schedule.

The PPV Programs consist of separate contracts which establish the fees for the distribution of pharmaceutical products that are distributed through the PPV Programs on Federal Government (i.e., Federal Supply Schedules, DLA National Contracts) contracts. The awardee consents to allow VA and DLA prime vendors to distribute the listed products in the schedule.

Work Details
Alendronate Sodium 35MG tablet – 4 Count (4 blister tablets of 1 card per box) National Drug Code (NDC) - - Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Alendronate Sodium 70MG tablet – 4 Count (4 blister tablets of 1 card per box) National Drug Code (NDC) - - Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
NOTE: REQUIREMENTS FOR THE DEPARTMENT OF DEFENSE (DoD) SERVICE DEMAND ONLY *BX = BOX (4 blister tablets of 1 card per box) -The quantities specified in the Schedule are estimates only.

Period of Performance
June 08, 2024 through June 07, 2025

Place of Performance
The product will be delivered to multiple PPV distribution centers for distribution to the participants under this contract.